This site provides information on the EPIC study and details on case recruitment for veterinary professionals worldwide. Pimobendan is a prescription only medicine, licensed for the treatment of congestive heart failure due to mitral valve disease or dilated cardiomyopathy.

The EPIC Trial site is intended for veterinary professionals. By clicking 'Continue' you are affirming that you are a veterinary professional.

Evaluating Pimobendan in Cardiomegaly
Media & Journalists  •  Contact  •  Helpful Links  •  FAQs  •  Site Map

EPIC Trial

Welcome to the EPIC Trial, a groundbreaking new study advancing canine heart disease treatment.

Learn More »

Investigator Sign in

Investigators, please sign in here.

Study Design

Learn more about EPIC and canine heart disease

Trial Locations

36 investigators, 11 countries, four continents



An investigator's point of view



The latest study updates


The answers to most of your questions

About the Trial

Learn more about the history of the EPIC Trial, how it came to be and what the study aims to uncover.

EPIC Trial Progress

Click here to see how many dogs are currently enrolled and to track the growth of the EPIC Trial.

What is MMVD and CHF?

Understanding canine heart disease.